Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105239713 | 10523971 | 3 | F | 20140926 | 20160324 | 20141017 | 20160331 | EXP | KR-AMGEN-KOROT2014079229 | AMGEN | 74.00 | YR | E | M | Y | 48.00000 | KG | 20160331 | MD | KR | KR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105239713 | 10523971 | 1 | PS | G-LASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 1X/3WEEKS | 125031 | 6 | MG | SOLUTION FOR INJECTION | Q3W | ||||||
| 105239713 | 10523971 | 2 | SS | GRAN | FILGRASTIM | 1 | Subcutaneous | 150 MUG, PRN | 0 | 150 | UG | INJECTION | |||||||
| 105239713 | 10523971 | 3 | C | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 71 MG, UNK | 0 | 71 | MG | INJECTION | |||||||
| 105239713 | 10523971 | 4 | C | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | 37 MG, UNK | 0 | 37 | MG | INJECTION | |||||||
| 105239713 | 10523971 | 5 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 500 MG, UNK | 0 | 500 | MG | INJECTION | |||||||
| 105239713 | 10523971 | 6 | C | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | 2380 MG, UNK | 0 | 2380 | MG | INJECTION | |||||||
| 105239713 | 10523971 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 20 MG, UNK | 0 | 20 | MG | INJECTION | |||||||
| 105239713 | 10523971 | 8 | C | RIFAMPIN. | RIFAMPIN | 1 | Oral | 450 MG, UNK | 0 | 450 | MG | ||||||||
| 105239713 | 10523971 | 9 | C | PYRAZINAMIDE. | PYRAZINAMIDE | 1 | Oral | 1500 MG, UNK | 0 | 1500 | MG | ||||||||
| 105239713 | 10523971 | 10 | C | ETHAMBUTOL HCL | ETHAMBUTOL HYDROCHLORIDE | 1 | Oral | 800 MG, UNK | 0 | 800 | MG | ||||||||
| 105239713 | 10523971 | 11 | C | ISONIAZID. | ISONIAZID | 1 | Oral | 300 MG, UNK | 0 | 300 | MG | ||||||||
| 105239713 | 10523971 | 12 | C | SALBUTAMOL SULFATE | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 20 ML, UNK | 0 | 20 | ML | ||||||||
| 105239713 | 10523971 | 13 | C | MEROPENEM TRIHYDRATE | MEROPENEM | 1 | Intravenous (not otherwise specified) | 1500 MG, UNK | 0 | 1500 | MG | INJECTION | |||||||
| 105239713 | 10523971 | 14 | C | CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | 1 | Intravenous (not otherwise specified) | 50 MG, UNK | 0 | 50 | MG | INJECTION | |||||||
| 105239713 | 10523971 | 15 | C | MEGESTROL ACETATE. | MEGESTROL ACETATE | 1 | Oral | 1PK,UNK | 0 | ||||||||||
| 105239713 | 10523971 | 16 | C | SEPTRIN | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 2TAB,UNK | 0 | ||||||||||
| 105239713 | 10523971 | 17 | C | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 2 G, UNK | 0 | 2 | G | INJECTION | |||||||
| 105239713 | 10523971 | 18 | C | PROPACETAMOL HCL | 2 | Intravenous (not otherwise specified) | 2 G, UNK | 0 | 2 | G | INJECTION | ||||||||
| 105239713 | 10523971 | 19 | C | TNA PERI | 2 | Intravenous (not otherwise specified) | 1680 ML, UNK | 0 | 1680 | ML | INJECTION | ||||||||
| 105239713 | 10523971 | 20 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 200 MG, UNK | 0 | 200 | MG | ||||||||
| 105239713 | 10523971 | 21 | C | APREPITANT. | APREPITANT | 1 | Oral | 80 MG, UNK | 0 | 80 | MG | ||||||||
| 105239713 | 10523971 | 22 | C | RAMOSETRON HCL | 2 | Oral | 0.1 MG, UNK | 0 | .1 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105239713 | 10523971 | 1 | Febrile neutropenia |
| 105239713 | 10523971 | 2 | Febrile neutropenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105239713 | 10523971 | DE |
| 105239713 | 10523971 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105239713 | 10523971 | Disease progression | |
| 105239713 | 10523971 | Febrile neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105239713 | 10523971 | 1 | 20140923 | 20140923 | 0 | |
| 105239713 | 10523971 | 2 | 20140926 | 20140928 | 0 | |
| 105239713 | 10523971 | 3 | 20140918 | 20140921 | 0 | |
| 105239713 | 10523971 | 4 | 20140918 | 20140921 | 0 | |
| 105239713 | 10523971 | 5 | 20140918 | 20140921 | 0 | |
| 105239713 | 10523971 | 6 | 20140918 | 20140921 | 0 | |
| 105239713 | 10523971 | 7 | 20140918 | 20140930 | 0 | |
| 105239713 | 10523971 | 8 | 20140920 | 20140930 | 0 | |
| 105239713 | 10523971 | 9 | 20140920 | 20140930 | 0 | |
| 105239713 | 10523971 | 10 | 20140920 | 20140930 | 0 | |
| 105239713 | 10523971 | 11 | 20140920 | 20140930 | 0 | |
| 105239713 | 10523971 | 12 | 20140925 | 20140930 | 0 | |
| 105239713 | 10523971 | 13 | 20140926 | 20140930 | 0 | |
| 105239713 | 10523971 | 14 | 20140927 | 20140930 | 0 | |
| 105239713 | 10523971 | 15 | 20140922 | 20140930 | 0 | |
| 105239713 | 10523971 | 16 | 20140916 | 20140930 | 0 | |
| 105239713 | 10523971 | 17 | 20140926 | 20140929 | 0 | |
| 105239713 | 10523971 | 18 | 20140926 | 20140929 | 0 | |
| 105239713 | 10523971 | 19 | 20140913 | 20140930 | 0 | |
| 105239713 | 10523971 | 20 | 20140916 | 20140925 | 0 | |
| 105239713 | 10523971 | 21 | 20140919 | 20140920 | 0 | |
| 105239713 | 10523971 | 22 | 20140920 | 20140921 | 0 |